Family based association study of MMP-9 gene-1562C>T polymorphism in schizophrenia;Asocjacyjne badania rodzinne polimorfizmu -1562C>T genu MMP-9 w schizofrenii

Psychiatria Polska

Volumn 45, Issue 3, 2011, Pages 317-324

  Groszewska, Agata ^a,c   Kapelski, Paweł ^b   Skibińska, Maria ^a   Hauser, Joanna ^a,b  

^a Zakład Genetyki W Psychiatrii Katedry Psychiatrii UM ^*  (Poland)

^b Poznan University of Medical Sciences   (Poland)

^c POZNA UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

MMP 9; Schizophrenia; TDT

Indexed keywords

GELATINASE B;

ARTICLE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; NERVE CELL DIFFERENTIATION; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHIZOPHRENIA; TRANSMISSION DISEQUILIBRIUM TEST;

ADULT; COHORT STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PEDIGREE; POLAND; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; SCHIZOPHRENIA; YOUNG ADULT;

EID: 79959304874     PISSN: 00332674     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry 1987; 44: 660-669.
2. Murray RM, Lewis SW. Is schizophrenia a neurodevelopmental disorder? Brit. Med. J. 1987; 295: 681-682.
3. Bearden CE, Rosso IM, Hollister JM i in. A prospective cohort study of childhood behavioral deviance and language abnormalities as predictors of adult schizophrenia. Schizophr. Bull. 2000; 26: 395-410.
4. Kunugi H, Nanko S, Murray RM. Obstetric complications and schizophrenia: prenatal under-development and subsequent neurodevelopmental impairment. Brit. J. Psychiatry 2001; 40: 25-29.
5. Rosa A, Cuesta MJ, Peralta V i in. Dermatoglyphic anomalies and neurocognitive deficits in sibling pairs discordant for schizophrenia spectrum disorders. Psychiatry Res. 2005; 137: 215-221.
6. Gourion D, Goldberger C, Bourdel MC i in. Minor physical anomalies in patients with schizophrenia and their parents: prevalence and pattern of craniofacial abnormalities. Psychiatry Res. 2004; 125: 21-28.
7. Arango C, Kirkpatrick B, Buchanan RW. Neurological signs and the heterogeneity of schizophrenia. Am. J. Psychiatry 2000; 157: 560-565.
8. Brambilla P, Cerini R, Gasparini A i in. Investigation of corpus callosum in schizophrenia with diffusion imaging. Schizophr. Res. 2005; 79: 201-210.
9. Chance SA, Esiri MM, Crow TJ. Amygdala volume in schizophrenia: post-mortem study and review of magnetic resonance imaging findings. Brit. J. Psychiatry 2002; 180: 331-338.
10. Fannon D, Chitnis X, Doku V i in. Features of structural brain abnormality detected in first-episode psychosis. Am. J. Psychiatry 2000; 157: 1829-1834.
11. Konarski JZ, McIntyre RS, Grupp LA i in. Is the cerebellum relevant in the circuitry of neuropsychiatric disorders? J. Psychiatry Neurosc. 2005; 30: 178-186.
12. Paillere-Martinot M, Caclin A, Artiges E i in. Cerebral gray and white matter reductions and clinical correlates in patients with early onset schizophrenia. Schizophr. Res. 2001; 50: 19-26.
13. Geuze E, Vermetten E, Bremner JD. MR-based in vivo hippocampal volumetrics: 2. Findings in neuropsychiatric disorders. Mol. Psychiatry 2005; 10: 160-184.
14. Clinton SM, Meador-Woodruff JH. Thalamic dysfunction in schizophrenia: neurochemical, neuropathological, and in vivo imaging abnormalities. Schizophr. Res. 2004; 69: 237-253.
15. Rioux L, Nissanov J, Lauber K i in. Distribution of microtubule- associated protein MAP2-immunoreactive interstitial neurons in the parahippocampal white matter in subjects with schizophrenia. Am. J. Psychiatry 2003; 160: 149-155.
16. Rajkowska G, Selemon LD, Goldman-Rakic PS. Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Arch. Gen. Psychiatry 1998; 55: 215-224.
17. Breakspear M, Terry JR, Friston KJ i in. A disturbance of nonlinear interdependence in scalp EEG of subjects with first episode schizophrenia. Neuroim. 2003; 20: 466-478.
18. Monfils MH, Teskey GC. Induction of long-term depression is associated with decreased dendritic length and spine density in layers III and V of sensorimotor neocortex. Synapse 2004; 53: 114-121.
19. Dityatev A, Schachner M. Extracellular matrix molecules and synaptic plasticity. Nat. Rev. Neurosc. 2003; 4: 456-468.
20. Vaillant C, Didier-Bazes M, Hutter A i in. Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum. J. Neurosc. 1999; 19: 4994-5004.
21. Cockle JV, Gopichandran N, Walker JJ i in. Matrix metalloproteinases and their tissue inhibitors in preterm perinatal complications. Reprod. Sc. 2007; 14: 629-645.
22. Natarajan G, Shankaran S, McDonald SA i in. Circulating beta chemokine and MMP 9 as markers of oxidative injury in extremely low birth weight infants. Pediatr. Res. 2010; 67: 77-82.
23. Sunagawa S, Ichiyama T, Honda R i in. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in perinatal asphyxia. Brain Dev. 2009; 31: 588-593.
24. Tong W, Chen W, Ostrowski RP i in. Maternal hypoxia increases the activity of MMPs and decreases the expression of TIMPs in the brain of neonatal rats. Dev. Neurobiol. 2010; 70: 182-194.
25. Zhang B, Henney A, Eriksson P i in. Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1. Hum. Genet. 1999; 105: 418-423.
26. Nagy V, Bozdagi O, Matynia A i in. Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory. J. Neurosc. 2006; 26: 1923-1934.
27. Kaczmarek L, Lapinska-Dzwonek J, Szymczak S. Matrix metalloproteinases in the adult brain physiology: a link between c-Fos, AP-1 and remodeling of neuronal connections? EMBO J. 2002; 21: 6643-6648.
28. Michaluk P, Kaczmarek L, Rylski M. Proteomika proteaz na przykładzie możliwej roli MMP-9 w plastyczności synaptycznej. Neuropsychiatr. Neuropsychol. 2008; 3: 95-106.
29. Hughes S, Agbaje O, Bowen RL i in. Matrix metalloproteinase single-nucleotide polymorphisms and haplotypes predict breast cancer progression. Clin. Cancer Res. 2007; 13: 6673-6680.
30. Zhang B, Ye S, Herrmann SM i in. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulat. 1999; 99: 1788-1794.
31. Rybakowski JK, Skibinska M, Leszczynska-Rodziewicz A i in. Matrix metalloproteinase-9 gene and bipolar mood disorder. Neuromol. Med. 2009; 11: 128-132.
32. Rybakowski JK, Skibinska M, Kapelski P i in. Functional polymorphism of the matrix metalloproteinase-9 (MMP-9) gene in schizophrenia. Schizophr. Res. 2009; 109: 90-93.
33. Diagnostic and statistical manual of mental disorders. Fourth edition. Waszyngton: American Psychiatric Association; 1994.
34. International classification of disease - ten revision (ICD-10). The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostics quidelines. Genva: WHO; 1992.
35. First MB, Spitzer RL, Gibbon M i in. User's guide for the Structured Clinical Interview for Dsm-IV axis I disorders - research version (SCID-1, version 2.0, February 1996, FINAL version).
36. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16: 1215.
37. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 1993; 52: 506-516.